Europe Continuous Bioprocessing Market to be Worth $206.1 Million by 2030- Exclusive Report by Meticulous Research®
20 sept. 2023 09h00 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Sept. 20, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, “Europe Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges,...
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
20 sept. 2023 08h26 HE
|
Evaxion Biotech
Partnership based on a highly protective vaccine candidate identified by Evaxion’s EDEN™ platformThe collaboration will access mRNA technology from the WHO and Medicines Patent Pool’s mRNA Vaccine...
HilleVax Announces Pricing of Public Offering of Common Stock
19 sept. 2023 20h05 HE
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...
HilleVax Announces Proposed Public Offering of Common Stock
19 sept. 2023 16h09 HE
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global Impact, on Behalf of the Advancing Health Online Initiative (AHO), Announces Collaboration with Gavi, the Vaccine Alliance at the Concordia Annual Summit
19 sept. 2023 14h00 HE
|
Global Impact
New York, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alongside the 78th United Nations General Assembly, Global Impact as fiscal sponsor for the Advancing Health Online Initiative (AHO), announced...
Foundation for Sarcoidosis Research partners with 95 Walgreens stores in Alabama to raise awareness of sarcoidosis and the importance of all impacted by heart and lung disease to get vaccinated
15 sept. 2023 15h23 HE
|
Foundation for Sarcoidosis Research
CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Beginning September 16th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of...
Sabin Vaccine Institute Leads Public and Private Sector Fight to Prevent HPV and End Cervical Cancer with Global HPV Consortium Launch in Kuala Lumpur
04 sept. 2023 18h00 HE
|
Sabin Vaccine Institute
KUALA LUMPUR, Malaysia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The Global HPV Consortium, a worldwide public and private collaboration focused on accelerating prevention of Human Papillomavirus (HPV) and...
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 août 2023 16h05 HE
|
Icosavax, Inc.
- Positive topline interim Phase 1 results for bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults - - Positive twelve-month immunogenicity data and initial proof-of-concept...
HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
14 août 2023 07h00 HE
|
HilleVax, Inc.
BOSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Icosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination Potential
08 août 2023 16h05 HE
|
Icosavax, Inc.
- In new data from Icosavax’s IVX-121 Phase 1b extension trial in older adults, GMTs against RSV through day 365 persisted at ~45-70% of the GMTs at day 28 (for 75 and 250 µg unadjuvanted dosages) - ...